Press release
Atopic Dermatitis Market Forecast to Hit USD 22.37 Billion by 2034 | CAGR: 8.5%
The global atopic dermatitis market is projected to witness a growth rate of 8.5% from 2025 to 2034. It is projected to reach USD 22.37 billion by 2034 from USD 9.93 billion in 2024, according to an analysis by Polaris Market Research.
Market Outlook
Atopic dermatitis is a skin condition that causes dry, itchy, and inflamed skin. It is a normal affair in young children but can impact grown ups also. It is prolonged and is inclined to flare sometimes. It can be exasperating but is not contagious. People with atopic dermatitis have the probability of developing food susceptibilities, hay fever, and asthma. Moisturizing often and ensuing other skin care patterns can mitigate itching and prohibit contemporary outbreaks.
Several alternatives are available to assist regulate itching and mend the skin. Commodities are obtainable in several forms and as creams, gels and ointments. For a more developed eczema, the healthcare provider may prescribe pills to assist regulate the symptoms of eczema treatment.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size/request-for-sample
Market Drivers
Growing Cases of Atopic Dermatitis: There is a growing aggregate of atopic dermatitis cases globally. As per the International Eczema Council, roughly 223 million persons globally were affected by atopic dermatitis in 2022. The growing existence underscores the rising demand for productive cures and handling schemes. Thus the growing existence of atopic dermatitis fuels the atopic dermatitis market demand.
Innovations in Biologic Cures: Inventions in biologic cures have transformed the therapeutic landscape for atopic dermatitis. Biotechnology and pharmaceutical firms are concentrating on advancing new therapeutic alternatives involving targeted biologics, miniature molecular inhibitors, and immunomodulators. These inventive drugs provide improved productivity and security profiles. Thus, the growing progression of biologics for atopic dermatitis drives the market growth.
Top Companies
The market is excessively competitive. Some of the key players in the market are:
• AbbVie Inc.
• Allergan plc
• Almirall, S.A.
• Astellas Pharma Inc.
• Bayer AG
• Eli Lilly and Company
• Galderma S.A.
• Incyte Corporation
• LEO Pharma A/S
• Novartis AG
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.
• Sanofi S.A.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size/request-for-discount-pricing
Atopic Dermatitis Industry Developments
• July 2024: Kymera Therapeutics, a clinical-stage biopharmaceutical company, announced that Sanofi would expand the Phase 2 trial of KT-474-an investigational therapy for autoimmune skin disorders including atopic dermatitis-after encouraging safety and efficacy data were observed during initial reviews.
• July 2024: Arcutis Biotherapeutics, Inc., a commercial-stage company specializing in immuno-dermatology, received approval from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) for ZORYVE® (roflumilast) cream 0.15%. The cream is now approved for treating mild to moderate atopic dermatitis in adults and children aged six and older.
• January 2024: Glenmark Pharmaceuticals Ltd. partnered with Pfizer to introduce abrocitinib in India. This marks the launch of the first oral advanced systemic therapy for moderate-to-severe atopic dermatitis in the country, offering a novel treatment option for patients with inadequate response to topical therapies.
Atopic Dermatitis Market Report Highlights
• The atopic dermatitis market, by drug class, is segmented into biologics, calcineurin inhibitors, corticosteroids, PDE4 inhibitors, and others. The biologics segment accounted for a major market share in 2024.
• The market, by route of administration, is segmented into topical, injectable, and oral. The injectable segment dominated the atopic dermatitis market share in 2024. This dominance is largely attributed to the widespread adoption of injectable biologic therapies.
• North America accounted for a major share of the atopic dermatitis market revenue in 2024 due to the high prevalence of atopic dermatitis and substantial healthcare expenditures.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/global-atopic-dermatitis-market-size
Segment Insights
The atopic dermatitis market is segmented by drug class, route of administration, therapy, and region.
Based on drug class, the biologics segment accounted for a major market share in 2024 as progressive therapies such as interleukin inhibitors are usually prescribed for severe cases.
Based the route of administration, the injectable segment held the largest market share in 2024 due to the rising adoption of injectable biologic therapies, such as Dupilumab, which have been effective in handling ordinary to severe cases.
Atopic Dermatitis Market, Drug Class Outlook (Revenue - USD Billion, 2020-2034)
• Biologics
• Calcineurin Inhibitors
• Corticosteroids
• PDE4 Inhibitors
• Others
Atopic Dermatitis Market, Route of Administration Outlook (Revenue - USD Billion, 2020-2034)
• Topical
• Injectable
• Oral
Atopic Dermatitis Market, Therapy Outlook (Revenue - USD Billion, 2020-2034)
• Photo Therapy
• Directed Therapy
Regional Perspective
• North America
o US
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe
More Trending Latest Reports by Polaris Market Research:
Background Music Market
https://www.polarismarketresearch.com/industry-analysis/background-music-market
Marine Seats Market
https://www.polarismarketresearch.com/industry-analysis/marine-seat-market
Zeolite Market
https://www.polarismarketresearch.com/industry-analysis/zeolite-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis Market Forecast to Hit USD 22.37 Billion by 2034 | CAGR: 8.5% here
News-ID: 3998616 • Views: …
More Releases from Polaris Market Research & Consulting
Aerospace Fasteners Market Expected to Reach USD 11.52 Billion by 2034 at 6.3% C …
The quantitative market research report published by Polaris Market Research on Aerospace Fasteners Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Aerospace Fasteners Market size, financial data, and projected future growth. All the information presented…
5G Chipset Market Poised to Reach $249.8 Billion by 2034, Exhibiting 23.40% CAGR …
The quantitative market research report published by Polaris Market Research on 5G Chipset Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, 5G Chipset Market size, financial data, and projected future growth. All the information presented…
Water Desalination Equipment Market Set to Achieve $15.69 Billion by 2030 with 9 …
The quantitative market research report published by Polaris Market Research on Water Desalination Equipment Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Water Desalination Equipment Market size, financial data, and projected future growth. All the…
Asphalt Pavers Market Anticipated to Reach USD 3.32 Billion by 2034, Recording 4 …
The quantitative market research report published by Polaris Market Research on Asphalt Pavers Market aims to educate users with an in-depth understanding of a rapidly growing market. The study details important facts and figures, expert opinions, and major developments across the globe. The research study serves as a vital source of information with the historical data, Asphalt Pavers Market size, financial data, and projected future growth. All the information presented…
More Releases for Atopic
Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Atopic Dermatitis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The scope of the atopic dermatitis market has experienced substantial expansion recently, projected to increase from $8.61 billion in 2024 to reach $9.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.7%;…
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
